Brief: Ryvu Therapeutics Signs 18.9 Mln Zloty Grant Deal For Tumor Drug Project
18/03/2021 08:50
March 18 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS 18.9 MILLION ZLOTY GRANT DEAL WITH POLAND'S CENTRE
FOR
RESEARCH AND DEVELOPMENT
* GRANT IS FOR SOLID TUMORS DRUG CANDIDATE PROJECT OF TOTAL
NET
VALUE 42.7 MILLION ZLOTYS
Source text for Eikon: ID:nEM3GykNsa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project